0001213900-24-111548.txt : 20241223 0001213900-24-111548.hdr.sgml : 20241223 20241223091856 ACCESSION NUMBER: 0001213900-24-111548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241220 FILED AS OF DATE: 20241223 DATE AS OF CHANGE: 20241223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baldasare Bryan T CENTRAL INDEX KEY: 0001761920 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 241570300 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 4 1 ownership.xml X0508 4 2024-12-20 0 0001728328 InMed Pharmaceuticals Inc. INM 0001761920 Baldasare Bryan T C/O INMED PHARMACEUTICALS INC. 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C3E8 BRITISH COLUMBIA, CANADA 1 0 0 0 0 Employee Stock Option (Right to Buy) 4.14 2024-12-20 4 A 0 550 0.00 A 2029-12-19 Common shares 550 975 D The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner. On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. /s/ Eric A Adams, attorney-in-fact for Mr. Bryan Baldasare 2024-12-23